Physiological characterization of a mouse model of cachexia in colorectal liver metastases
Open Access
- 15 May 2013
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 304 (10) , R854-R864
Abstract
Loss of skeletal muscle mass and function (cachexia) is severe in patients with colorectal liver metastases because of the large increase in resting energy expenditure but remains understudied because of a lack of suitable preclinical models. Our aim was to characterize a novel preclinical model of cachexia in colorectal liver metastases. We tested the hypothesis that mice with colorectal liver metastases would exhibit cachexia, as evidenced by a reduction in liver-free body mass, muscle mass, and physiological impairment. Twelve-week-old male CBA mice received an intrasplenic injection of Ringer solution (sham) or murine colorectal cancer cells (MoCR) to induce colorectal liver metastases. At end-point (20–29 days), the livers of MoCR mice were infiltrated completely with metastases, and MoCR mice had reduced liver-free body mass, muscle mass, and epididymal fat mass compared with sham controls ( P < 0.03). MoCR mice exhibited impaired rotarod performance and grip strength ( P < 0.03). Histochemical analyses of tibialis anterior muscles from MoCR mice revealed muscle fiber atrophy and reduced oxidative enzyme activity ( P < 0.001). Adipose tissue remodeling was evident in MoCR mice, with reduced adipocyte diameter and greater infiltration of nonadipocyte tissue ( P < 0.05). These findings reveal the MoCR mouse model exhibits significant cachexia and is a suitable preclinical model of cachexia in colorectal liver metastases. This model should be used for identifying effective treatments for cachexia to improve quality of life and reduce mortality in patients with colorectal liver metastases.Keywords
This publication has 35 references indexed in Scilit:
- Effect of colon cancer and surgical resection on skeletal muscle mitochondrial enzyme activity in colon cancer patients: a pilot studyJournal of Cachexia, Sarcopenia and Muscle, 2012
- Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexiaDisease Models & Mechanisms, 2012
- The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ MousePLOS ONE, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patientsBritish Journal of Cancer, 2011
- Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic β-adrenoceptor stimulation in miceThe Journal of Physiology, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demandsThe American Journal of Clinical Nutrition, 2009
- Effect of branched-chain amino acids on muscle atrophy in cancer cachexiaBiochemical Journal, 2007
- Cachexia in cancer patientsNature Reviews Cancer, 2002